Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen
Spain
Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen
technology: Diagnostics
New method for the early detection of Calcific Aortic Valve Disease
Spain
New method for the early detection of Calcific Aortic Valve Disease
Diagnostic kit for acute myeloid leukemia and myelodysplasia
Italy
Diagnostic kit for acute myeloid leukemia and myelodysplasia
Identification of therapeutic agents for treatment of Covid-19
Italy
Identification of therapeutic agents for treatment of Covid-19
Finnish diagnostic SMEs offer their Upconverting Nanoparticles (UCNP) technology chemistry and detection tools to sales partners
Finland
Finnish diagnostic SMEs offer their Upconverting Nanoparticles (UCNP) technology chemistry and detection tools to sales partners
COVID-19: Seeking distributors for an accurate and sensitive PCR test for the detection of SARS-CoV-2
United Kingdom
COVID-19: Seeking distributors for an accurate and sensitive PCR test for the detection of SARS-CoV-2
A Korean company manufacturing ultra-fast COVID-19 diagnostic kits based on real-time PCR technology seeks distribution partners in Europe
South Korea
A Korean company manufacturing ultra-fast COVID-19 diagnostic kits based on real-time PCR technology seeks distribution partners in Europe
Monoclonal antibody for using in the diagnosis of nosemosis caused by the parasite Nosema ceranae.
Spain
Monoclonal antibody for using in the diagnosis of nosemosis caused by the parasite Nosema ceranae.
Immunoassay for detection of Pseudomonas aeruginosa Quorum Sensing molecules
Spain
Immunoassay for detection of Pseudomonas aeruginosa Quorum Sensing molecules
A Korean company specialised in in-vitro diagnostics is looking for partners, interested in developing and licensing, commercialising aptamer immuno-PCR technology for in-vitro diagnostics of prostate cancer.
South Korea
A Korean company specialised in in-vitro diagnostics is looking for partners, interested in developing and licensing, commercialising aptamer immuno-PCR technology for in-vitro diagnostics of prostate cancer.